Mixture risk assessment and human biomonitoring: Lessons learnt from HBM4EU
Mirjam Luijten1, Jelle Vlaanderen2, Andreas Kortenkamp3
1National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Human biomonitoring effectively assesses combined chemical exposures and mixture risk, revealing public health concerns. This research identifies key risk drivers in chemical mixtures and recommends policy development for safer environments.
Area of Science:
- Environmental Health Sciences
- Toxicology
- Risk Assessment
Background:
- Current chemical risk assessment primarily evaluates single substances, neglecting complex environmental mixtures.
- Assessing chemical mixtures is challenging due to the vast number of chemicals and limited data on actual human exposure.
- Existing mixture risk assessment (MRA) tools lack sufficient maturity for regulatory implementation.
Purpose of the Study:
- To investigate approaches for assessing combined exposures and MRA within the European Human Biomonitoring Initiative (HBM4EU).
- To provide recommendations for policy development and future research on chemical mixtures.
- To highlight the role of human biomonitoring in understanding real-life chemical exposures.
Main Methods:
- Utilized human biomonitoring data to assess internal exposures to chemical mixtures.
- Developed and applied novel approaches to identify co-occurrence patterns of chemicals.
- Engaged stakeholders through workshops to discuss and refine recommendations.
Main Results:
- Human biomonitoring effectively reveals population-wide exposure to real-life chemical mixtures.
- Identified specific chemicals acting as 'risk drivers' contributing significantly to health risks.
- Discovered clusters of co-occurring chemicals, often regulated under disparate legislative frameworks.
Conclusions:
- Chemical mixtures pose a significant public health concern, necessitating advanced assessment strategies.
- Human biomonitoring is a valuable tool for informing MRA and identifying key risk drivers.
- Recommendations for policy and further research were developed, emphasizing the need for integrated MRA approaches.
More Related Videos
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
09:27Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment
Published on: May 6, 2020
Related Concept Videos
Hazard Ratio
For example, in a clinical trial...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Hazard Rate
